Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × Vitamins × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Transitional Cell 1

Interventions

pembrolizumab 76 Gemcitabine 48 Nivolumab 41 Cisplatin 35 atezolizumab 34 Carboplatin 27 avelumab 25 enfortumab vedotin 23 Docetaxel 22 Magnetic Resonance Spectroscopy 17 Paclitaxel 15 Ipilimumab 15 Mitomycin 14 Specimen Handling 12 durvalumab 10 toripalimab 9 sacituzumab govitecan 9 Pemetrexed 8 vinflunine 7 cabozantinib 7 Taxes 7 Injections 6 Cyclophosphamide 6 Bevacizumab 6 tislelizumab 5 pemigatinib 5 Standard of Care 5 Fluorodeoxyglucose F18 5 Biopsy 5 lenvatinib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01490437 2014-09-25

PECULIAR

Asan Medical Center

Phase 2 Completed

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡